文献速递胸部肿瘤支持与姑息治疗

早期姑息治疗与晚期肺癌生存及死亡地点的关联

Association of Early Palliative Care Use With Survival and Place of Death Among Patients With Advanced Lung Cancer Receiving Care in the Veterans Health Administration.
PubMed 文献 · JAMA Oncol · 2019-01-01

诊断后31至365天接受姑息治疗与生存改善相关(aHR 0.47,95%CI 0.45-0.49),且与急性护理机构死亡风险降低相关(aOR 0.57,95%CI 0.52-0.64)。

要点

  • 诊断后31-365天接受姑息治疗与生存改善相关(aHR 0.47)。
  • 姑息治疗与急性护理机构死亡风险降低相关(aOR 0.57)。
  • 诊断后0-30天接受姑息治疗与生存下降相关(aHR 2.13)。

核心结论

  • 晚期肺癌患者中,姑息治疗与生存获益相关,应视为疾病修饰治疗的补充手段。
  • 姑息治疗与急性护理机构死亡风险降低相关。

研究设计与样本

  • 数据来自美国退伍军人事务部医疗系统,分析时间为2019年2月15日至2019年4月28日。
  • 采用倾向评分和时间依赖协变量方法计算Cox比例风险及回归模型。

主要发现

  • 与未接受姑息治疗相比,诊断后0-30天接受姑息治疗与生存下降相关(aHR 2.13,95%CI 1.97-2.30)。
  • 诊断后31-365天接受姑息治疗与生存改善相关(aHR 0.47,95%CI 0.45-0.49)。
  • 诊断后超过365天接受姑息治疗与生存无差异(aHR 1.00,95%CI 0.94-1.07)。
  • 姑息治疗与急性护理机构死亡风险降低相关(aOR 0.57,95%CI 0.52-0.64)。

临床怎么用

  • 对晚期肺癌患者,可考虑将姑息治疗作为疾病修饰治疗的补充手段。
  • 姑息治疗的时机可能与生存获益相关,需结合诊断后时间评估。

局限性

  • 回顾性队列设计,可能存在残余混杂。
  • 研究对象以男性退伍军人为主(98%),外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Palliative care is a patient-centered approach associated with improvements in quality of life; however, results regarding its association with a survival benefit have been mixed, which may be a factor in its underuse. OBJECTIVE: To assess whether early palliative care is associated with a survival benefit among patients with advanced lung cancer. DESIGN, SETTING, AND PARTICIPANTS: This retrospective population-based cohort study was conducted among patients with lung cancer who were diagnosed with cancer between January 1, 2007, and December 31, 2013, with follow-up until January 23, 2017. Participants comprised 23 154 patients with advanced lung cancer (stage IIIB and stage IV) who received care in the Veterans Affairs health care system. Data were analyzed from February 15, 2019, to April 28, 2019. EXPOSURE: Palliative care defined as a specialist-delivered palliative care encounter received after lung cancer diagnosis. MAIN OUTCOMES AND MEASURES: The primary outcome was survival. The association between palliative care and place of death was also examined. Propensity score and time-varying covariate methods were used to calculate Cox proportional hazards and to perform regression modeling. RESULTS: Of the 23 154 patients enrolled in the study, 57% received palliative care. The mean (SD) age of participants was 68 (9.5) years, and 98% of participants were men. An examination of the timing of palliative care receipt relative to cancer diagnosis found that palliative care received 0 to 30 days after diagnosis was associated with decreases in survival (adjusted hazard ratio [aHR], 2.13; 95% CI, 1.97-2.30), palliative care received 31 to 365 days after diagnosis was associated with increases in survival (aHR, 0.47; 95% CI, 0.45-0.49), and palliative care received more than 365 days after diagnosis was associated with no difference in survival (aHR, 1.00; 95% CI, 0.94-1.07) compared with nonreceipt of palliative care. Receipt of palliative care was also associated with a reduced risk of death in an acute care setting (adjusted odds ratio, 0.57; 95% CI, 0.52-0.64) compared with nonreceipt of palliative care. CONCLUSIONS AND RELEVANCE: The results suggest that palliative care was associated with a survival benefit among patients with advanced lung cancer. Palliative care should be considered a complementary approach to disease-modifying therapy in patients with advanced lung cancer.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Sullivan DR, Chan B, Lapidus JA, et al. Association of Early Palliative Care Use With Survival and Place of Death Among Patients With Advanced Lung Cancer Receiving Care in the Veterans Health Administration. JAMA Oncol. 2019. PMID: 31536133. doi:10.1001/jamaoncol.2019.3105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。